Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form?

Literature DB >> 29158358

Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form?

Murray Esler¹, Gavin Lambert², Markus Schlaich², John Dixon², Carolina Ika Sari², Elisabeth Lambert².

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 29158358 DOI： 10.1161/HYPERTENSIONAHA.117.09790

Source DB: PubMed Journal: Hypertension ISSN： 0194-911X Impact factor: 10.190

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors: Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal: Geroscience Date: 2018-12-05 Impact factor: 7.713

Review 2. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors: Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal: Can J Cardiol Date: 2020-02-12 Impact factor: 5.223

Review 3. Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors: John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal: Nat Rev Nephrol Date: 2019-06 Impact factor: 28.314

Review 4. Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.

Authors: Murray Esler; Marlies Alvarenga; David Barton; Garry Jennings; David Kaye; Ling Guo; Rosemary Schwarz; Gavin Lambert
Journal: Front Psychiatry Date: 2022-06-02 Impact factor: 5.435

Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form?

Review 1. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Review 2. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Review 3. Obesity, kidney dysfunction and hypertension: mechanistic links.

Review 4. Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.

Review 5. Sympathetic activation in congestive heart failure: an updated overview.

6. Pulse wave velocity is decreased with obesity in an elderly Chinese population.

7. Obesity is bad regardless of the obesity paradox for hypertension and heart disease.

8. Time-varying association between body mass index and all-cause mortality in patients with hypertension.

Review 9. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.

10. Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model.